Pearl Therapeutics

53 employees

Pearl develops a combination of products for the treatment of respiratory diseases, including chronic obstructive pulmonary disease.

Basic info

Industry

pharmaceuticals

Sectors

Infection

Biotechnology

Health Care

Immunology

Regulatory strategy

Biologics

Respiratory product development

High quality therapies for COPD and Asthma

Treatment and prevention of chronic respiratory diseases and asthma.

Inhaled therapeutics including MDIs and DPIs

Medical

Date founded

2020

Funding rounds raised

Total raised

$69M

from 26 investors over 26 rounds

Pearl Therapeutics raised $42M on April 1, 2013

Investors: New Leaf Venture Partners, Clarus Ventures, LLC, 5AM Ventures and Vatera Healthcare Partners

Pearl Therapeutics raised $65M on November 13, 2012

Investors: New Leaf Venture Partners, 5AM Ventures, Vatera Healthcare Partners and Clarus Ventures, LLC

Pearl Therapeutics raised $23M on October 1, 2012

Investors: 5AM Ventures, New Leaf Venture Partners, Vatera Healthcare Partners and Clarus Ventures, LLC

Pearl Therapeutics raised $69M on October 19, 2010

Investors: Vatera Healthcare Partners, New Leaf Venture Partners and 5AM Ventures

Pearl Therapeutics raised $15M on February 1, 2010

Investors: Clarus Ventures, LLC, New Leaf Venture Partners and 5AM Ventures

Pearl Therapeutics raised $8M on February 24, 2009

Investors: Oxford Finance LLC

Pearl Therapeutics raised $18M on July 3, 2008

Investors: Nektar Therapeutics, New Leaf Venture Partners, Clarus Ventures, LLC and 5AM Ventures

Pearl Therapeutics raised $16M on September 7, 2007

Investors: 5AM Ventures, New Leaf Venture Partners and Clarus Ventures, LLC